Adenoid cystic carcinoma of the sinonasal tract: treatment results by Rhee, C. S. et al.
The Laryngoscope
Lippincott Williams & Wilkins, Inc.
© 2006 The American Laryngological,
Rhinological and Otological Society, Inc.
Adenoid Cystic Carcinoma of the Sinonasal
Tract: Treatment Results
Chae-Seo Rhee, MD; Tae-Bin Won, MD; Chul Hee Lee, MD; Yang-Gi Min, MD; Myung-Whun Sung, MD;
Kwang-Hyun Kim, MD; Woo Sub Shim, MD, Yong Min Kim, MD; Jeong-Whun Kim, MD
Objectives: Malignancies arising from the sinona-
sal tract, which includes the nose, paranasal sinuses,
and nasopharynx, are uncommon. Although adenoid
cystic carcinoma (ACC) is the second most common
cancer occurring in the sinonasal tract, only few stud-
ies have been reported. This retrospective review was
performed to identify the clinical features and treat-
ment outcomes of sinonasal ACC. Methods: Thirty-five
patients diagnosed and treated for ACC of the sinona-
sal tract were included in this study. Medical records,
radiographs, and pathologic slides were retrospec-
tively reviewed. Results: In two thirds of the patients,
the maxillary sinus was the site of origin and cribri-
form was the most common histologic subtype (61%).
Seventy-one percent of the patients had advanced
disease (T3, T4) at the time of diagnosis. Five-year
overall survival rate was 86% and treatment failure
occurred in 18 patients (51%). Five-year local recur-
rence rate and distant metastasis rate were 30% and
25%, respectively. Adjunctive radiotherapy appeared
to reduce local recurrence. Presence of distant metas-
tasis correlated with decreased 5-year survival (P 
.001). Five-year survival rate after development of dis-
tant metastasis or local recurrence were 17% and 58%,
respectively. Conclusions: Based on our findings, we
suggest that sinonasal ACC be treated by a combined
modality of radical surgery followed by postoperative
radiation. The prognosis of sinonasal ACC seems to be
determined by the presence of distant metastasis. Key




The sinonasal tract is an uncommon primary site for
malignant disease. The incidence of sinonasal cancer is
predicted to be one in 100,000 per year. It comprises
approximately 3% of all the upper aerodigestive tract ma-
lignancies and less than 1% of all the cancers.1,2 Because
early manifestations mimic inflammatory diseases such
as chronic rhinitis and rhinosinusitis and because the
paranasal sinuses are air-filled spaces, diagnosis is often
delayed and is usually found in advanced stages. The
sinonasal tract adjourns functionally important struc-
tures, including the dura, brain, orbit, carotid arteries,
and cranial nerves. Therefore, treatment for the advanced
disease can result in serious morbidity. The most common
histology of cancers arising in the nasal cavity and the
paranasal sinuses is squamous cell carcinoma and is fol-
lowed by malignancies of salivary gland origin. Adenoid
cystic carcinoma (ACC) is the most common salivary gland
tumor in the sinonasal tract3–5 and accounts for 10% to
25% of all head and neck ACC.2,6,7
Despite the clinical implications, owing to the low
incidence of sinonasal ACC, clinical reports are lacking.
The present study aimed to identify the clinicopathologic
characteristics and treatment outcomes of sinonasal ACC.
MATERIALS AND METHODS
From 1979 through 2004, 35 patients treated in Seoul Na-
tional University Hospital and Seoul National University Bun-
dang Hospital under the diagnosis of ACC of the sinonasal tract
were included in this study. Medical records concerning site of
origin, initial and adjunctive treatment modality, and outcomes
were reviewed. Also, radiographs and pathologic slides were re-
viewed by one head and neck radiologist and one pathologist.
Eighteen males and 17 females were included in this study and
their mean age was 47 years. The main clinical manifestations
were cheek swelling, nasal obstruction, cheek pain, epistaxis,
nasal discharge, cheek hypoesthesia, and eyeball pain. The pa-
tients were clinically staged according to the guidelines of the
American Joint Committee on Cancer for each anatomic site.8
The average follow up after treatment was 64 months. To deter-
mine presence of lung metastasis, regular chest radiographs were
checked every 3 months for the first 2 years and every 6 months
thereafter. Disease-specific survival, local recurrence, and distant
metastasis rate were analyzed using the Kaplan-Meier method
and log-rank test. P value less than .05 was considered statisti-
cally significant.
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RESULTS
Clinicopathologic Characteristics of the Tumor
The primary tumor site were the nasal cavity (n  8),
the ethmoid sinus (n  1), the maxillary sinus (n  23),
and the nasopharynx (n  3). Half (n  17) of the patients
were diagnosed as stage T4 tumor. Most of the patients
did not have regional lymph node metastasis or distant
metastasis at the time of diagnosis (Table I). Pathologic
slides of 23 patients were reevaluated and were classified
into tubular, cribriform, or solid subtypes. Cribriform sub-
type (61%) was prevalent form, followed by tubular (22%)
and solid (17%) subtypes. Perineural invasion was more
frequently observed in solid subtype (75%) compared with
tubular (20%) or cribriform (50%) subtypes.
Treatment Modalities According to the
Primary Site
Treatment modality varied according to primary tu-
mor site (Table II). For ACC of the nasal cavity, surgical
resection of the primary tumor was performed as the
first-line treatment, except for stage T4 patients. Surgery
consisted of medial maxillectomy or subtotal maxillec-
tomy. Five of eight patients with ACC of the nasal cavity
underwent postoperative radiation therapy. The patient
with ACC of the ethmoid sinus showed skull base inva-
sion, and craniofacial resection was performed to remove
the tumor en bloc. For ACC of the nasopharynx, surgery
was not performed and all patients were treated by radi-
ation therapy alone. Eighteen of 23 patients with ACC of
the maxillary sinus underwent surgical resection of the
primary tumor followed by postoperative radiation. Total
maxillectomy and orbital exenteration was performed in
two patients in which the tumor involved periorbital tis-
sue and craniofacial resection was performed in two pa-
tients in whom the tumor invaded the skull base.
Treatment Results
Eighteen of 35 patients (51%) had treatment failures,
and these consisted of local recurrence (n  9 [26%]),
distant metastasis (n  4 [11%]), or both (n  5 [14%]).
There was no regional lymph node metastasis after treat-
ment (Table II). The time of local recurrence after treat-
ment ranged from 51  64 months. Distant metastasis
developed in nine patients; six patients developed pulmo-
nary metastasis, one bone metastasis, one liver metasta-
sis, and one both lung and bone metastasis. Distant me-
tastasis occurred 37  33 months after treatment.
Five- and 10-year treatment failure rate was 42% and
73%. Five- and 10-year local recurrence rate was 30% and
57%, and distant metastasis rate was 25% and 43%, re-
spectively (Fig. 1). Local recurrence rate was affected by
primary tumor stage. Advanced-stage (T3 and T4) tumors
were associated with higher local treatment failure com-
pared with early-stage (T1 and T2) tumors (P  .031) (Fig.
2). The 5-year local recurrence rate was 42% for advanced-
stage tumors, whereas no recurrence developed in the
early-stage tumors. In contrast, distant metastasis rate
was not significantly higher in advanced-stage tumors
compared with early-stage tumors (P  .21).
Perineural invasion was found in 14 of 23 patients
(60%) whose pathological slides were reevaluated. How-
ever, the presence of perineural invasion did not signifi-
cantly influence local recurrence rate (P  .90) or distant
metastasis rate (P  .48).
Disease-specific survival rate and local recurrence
rate appeared to be lower in patients treated with radical
surgery combined with postoperative radiotherapy than in
patients treated with other therapeutic modalities (P 
.17 and .09, respectively). However, distant metastasis
was not related to treatment modality (P  .75). Overall
disease-specific survival rate at 5 and 10 years was 86%
and 53%, respectively. Distant metastasis seemed to be an
important factor in determining survival. The 5- and 10-
year survival rate in patients without distant metastasis
were 100% and 69% respectively, whereas in patients with
distant metastasis, it was only 58% and 29% (P  .001 and
P  .002) (Fig. 3). The mean survival period after devel-
opment of distant metastasis was 25 months and the
5-year survival rate after occurrence of distant metastasis
was 17% (Fig. 4). On the other hand, local recurrence was
not a determining factor for survival (P  .89). The mean
survival period after local recurrence was 41 months and
the 5-year survival rate after tumor recurrence was 58%.
DISCUSSION
Various malignancies of salivary gland origin, includ-
ing adenocarcinoma, ACC, and mucoepidermoid carci-
noma, develop in the sinonasal tract.9 Among them, ACC
is a malignant tumor that shows peculiar biologic charac-
teristics. It tends to recur locally long after remission by
initial treatment. Three of the patients included in our
study had local recurrence 8 years after complete remis-
sion. Frequent and delayed distant metastasis is also one
of the characteristics. Based on the limited data, the
present study suggests that distant metastasis rate of
early-stage tumors is comparable to that of advanced-
stage tumors. However, these biologic features are yet
TABLE I.
Clinicopathologic Characteristics of the Patients with Adenoid
Cystic Carcinoma of the Sinonasal Tract Included in This Study.
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unexplainable. The unexpected biologic behavior of this
tumor presents a great challenge, often resulting in treat-
ment failures.
In accordance with other studies, two thirds of si-
nonasal ACCs in our study occurred in the maxillary sinus
and the most common pathologic subtype was cribriform.
The reason for the prevalence of the maxillary sinus as the
primary tumor site is unknown. Pathologically, the solid
subtype has more tumor cells than tubular or cribriform
subtypes and is usually known to show the worst progno-
sis among the three subtypes.2,10–12 However, whether the
pathologic subtype can serve as an independent prognosis-
determining factor in sinonasal ACC is unknown. In the
present study, as a result of the small number of patients
in each subtype, we could not determine whether the solid
subtype serves as a poor prognosticator, and future stud-
ies to clarify the influence of pathologic subtype are
needed.
Perineural invasion in ACC has been considered as
one of the determining factors for locoregional recurrence
or distant metastasis.13,14 However, our study did not
show significant correlation between perineural invasion
and local recurrence and distant metastasis.
Surgical resection with postoperative adjuvant radi-
ation therapy was the main therapeutic modality for ACC
of the nasal cavity and maxillary sinus. Although radia-
tion therapy is known to decrease local recurrence, its
contribution to survival is unclear, maybe because of the
high rate of distant metastasis.2,5 In the present study,
local recurrence rate was high in advanced-stage (T3 and
T4) tumors despite postoperative radiation therapy in
most of the patients. Therefore, complete resection of the
primary tumor with sufficient tumor-free margin is rec-
ommended. For instance, en bloc craniofacial resection,
including sinonasal and intracranial lesions for T4 lesions
with intracranial invasion,15 is advised over conservative
TABLE II.
Treatment Modalities of the Primary Tumor and Results.
Treatment Modalities
No. of Patients
Total No Evidence of Disease LR DM LR  DM
Nasal cavity
T1
Surgery only 1 1
T2
Surgery  postoperative radiation 3 1 1 1
T3
Surgery only 1 1
Surgery  postoperative radiation 2 2
T4
Radiation only 1 1
Ethmoid sinus
T4
Surgery only 1 1
Nasopharynx
T3
Radiation only 1 1
T4
Radiation only 2 1 1
Maxillary sinus
T2
Surgery  postoperative radiation 6 5 1
T3
Surgery  postoperative radiation 4 4
T4




Radiation only 2 2
Chemotherapy  radiation 2 1 1
Total 35 17 9 4 5
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resection. Radiotherapy alone does not appear to cure the
disease but probably plays a role in palliation. However,
chemotherapy did not result in palliation. Considering the
fact that most of the patients with sinonasal ACC were
diagnosed with advanced stages, further clinical trials
using multimodality therapeutic approaches aiming to re-
duce local recurrence are warranted.16
The 5-year survival rate was 86%, although the ini-
tial treatment failed in half of the patients included in this
study. This was attributed by delayed local recurrence and
distant metastasis. Other studies report treatment failure
rates ranging from 60% to 70% and 5-year survival rate
around 50%.5,17 The better results shown in the present
study might be explained by the lower rate of distant
metastasis compared with other studies17 and by the use
of radical resection as the surgical modality. Although the
overall distant metastasis rate of sinonasal ACC was
lower compared with other studies, the determining factor
for survival was also the presence of distant metastasis
and not local recurrence.
ACC is different from squamous cell carcinomas of
the head and neck in that cervical lymph node metastases
are uncommon. However, the presence of lymph node me-
tastasis is regarded as a poor prognostic factor to distant
Fig. 1. Treatment failures. Treatment failure, including local recur-
rence and distant spread, occurred in 51% of the patients. Five-year
local recurrence and distant metastasis rates were 30% and 25%,
respectively.
Fig. 2. Local recurrence rate. Advanced-staged tumors (T3, T4)
locally recurred more frequently than early-staged tumors (T1, T2) (P
 .031).
Fig. 3. Disease-specific survival rate. Distant metastasis of sinona-
sal adenoid cystic carcinoma predicted a poorer prognosis (P 
.001).
Fig. 4. Disease-specific survival rate after occurrence of distant
metastasis. After distant metastasis developed, 5-year survival rate
was 17% and median survival period was 25 months.
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metastasis and survival.17 Other studies have reported
occurrence of regional lymph node metastasis in 10% to
15% of head and neck ACC.2,6,17 In the present study,
lymphatic spread was found in only two patients (6%) at
the time of diagnosis and regional nodal recurrence did
not occur. The low rate of nodal metastasis for sinonasal
ACC compared with other ACCs of the head and neck
might be accounted for by the sparse lymphatic distribu-
tion in the sinonasal tract and surrounding structures.
In summary, based on the limited data, the present
study suggests that whenever sinonasal ACC is resect-
able, radical surgical resection and adjuvant postopera-
tive radiotherapy is recommended to reduce local recur-
rence rate. Although distant metastasis is uncommon in
sinonasal ACC compared with ACC of other head and
neck areas, it seems to determine survival. In the future,
a multimodality treatment approach, including adjuvant
chemotherapy, surgery, and radiation therapy, is war-
ranted to further prevent local recurrence and distant
metastasis.
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